Armata Pharmaceuticals, Inc. (ARMP) income statement
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.03+0.05 (+1.68%)
Close on Nov 20, 2026Market cap $112.66MP/E –Yield –
Armata Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?